A biotechnology company decoding the immune system to improve how disease is understood, diagnosed, and treated. The company combines high-fidelity multi-omic analysis with proprietary machine learning analytics to measure the immune system from a simple blood sample and is building a universal standard for immune profiling.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| $53 M | Jun, 2026 | series-a |
Industries
Frequently Asked Questions
Where is IMU Biosciences located?
IMU Biosciences is located in London, United Kingdom.
What industries does IMU Biosciences operate in?
IMU Biosciences operates in the following industries: biotechnology, healthtech, artificial intelligence.
Who are the investors in IMU Biosciences?
The investors in IMU Biosciences are: IQ Capital, Molten Ventures, The British Business Bank, Meltwind.